Article Text

other Versions

Download PDFPDF
Review
Outcome and its predictors in Guillain–Barré syndrome
  1. Yusuf A Rajabally1,
  2. Antonino Uncini2
  1. 1Neuromuscular Clinic, Department of Neurology, University Hospitals of Leicester, Leicester, UK
  2. 2Department of Neuroscience and Imaging, University “G. d'Annuzio”, Chieti-Pescara, Italy
  1. Correspondence to Dr Yusuf A Rajabally, Neuromuscular Clinic, Department of Neurology, University Hospitals of Leicester, Leicester General Hospital, Leicester LE5 4PW, UK; yusuf.rajabally{at}uhl-tr.nhs.uk

Abstract

Despite the use of plasma exchanges and intravenous immunoglobulins, Guillain-Barré syndrome (GBS) still carries non-negligible morbidity and mortality. Furthermore, the psychosocial consequences of GBS may persist longer than expected. Various aetiological, clinical, electrophysiological and immunological factors may carry prognostic predictive value. The objective of this article was to perform a summary of the current knowledge-base on outcome and its determinants in adequately-treated adult-onset GBS. Relevant prospective literature was reviewed through a Medline search of English-language articles published between 1966 and March 2012. GBS causes severe persistent disability in 14% of patients at 1 year. Loss of full strength, persistent pain and need for professional change occurs in about 40%. Mortality is of about 4% within the first year. Analysis of prognostic predictors consistently demonstrates the negative impact of higher age, preceding diarrhoea, greater disability/weaker muscles at admission, short interval between symptom-onset and admission, mechanical ventilation and absent/low amplitude compound muscle action potentials. Further outcome studies will soon be underway and may in future contribute to adequately integrate all potential factors in more reliable predictive models.

  • Adult-onset
  • Guillain–Barré syndrome
  • outcome
  • predictors
  • prognosis
  • clinical neurology
  • EMG
  • neuropathy

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.